The key question is whether the small reduction in depression and anxiety potentially associated with RRM justifies the possible small decline in quality of life, body image satisfaction, and sexual well-being for the individual carrier of a P/LP variant in BRCA1/2. This evidence concerns the gene BRCA1 and major depressive disorder.